![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bergqvist D., Lindgren B. and Matzsch T. (1996) Comparison of the cost of preventing post-operative deep vein thrombosis with either unfractionated or low molecular weight heparin. British Journal of Surgery, 83, 1548–1552.
- British Medical Association (BMA) (2001) Parenteral antic-oagulants. British National Formulary, 42, 114.
- Burrows R.F., Gan E.T., Gallus AS., Wallace E.M. and Burrows E.A. (2001) A randomised double-blind placebo controlled trial of low molecular weight heparin as prophy-laxis in preventing venous thrombolic events after caesarean section: a pilot study. British Journal of Obstetrics and Gynaecology, 108, 835–839.
- Lewis G. and Drife J. (2001) Why Mothers Die 1997-99. Confidential Enquiries into Maternal Deaths in the United Kingdom. London, RCOG Press.
- Hull and East Yorkshire Hospitals NHS Trust (1999) Thromboprophylaxis and Acute Management of Venous and Pulmonary Thromboembolism. Guideline no. 38.
- Madden S. and Porter T.F. (1999) Deep venous thrombosis: prophylaxis in gynaecology (controversies in gynaecology). Clinical Obstetrics and Gynaecology, 42, 895–901.
- McLeod R.S., Geerts W.H., Sniderman K.W., Greenwood C., Gregoire R.C., Taylor B.M., Silverman RE., Atkinson KG., Bernstein M., Marshall J.C., Burul C.J., Anderson DR., Ross T., Wilson S.R. and Barton P. (2001) Subcutaneous heparin versus low-molecular-weight heparin as thrombo-prophylaxis in patients undergoing colorectal surgery: results of the Canadian Colorectal DVT Prophylaxis Trial: a randomized, double-blind trial. Annals of Surgery, 233, 438–444.
- Mismetti P., Laporte S., Darman J.Y., Buchmuller A. and Descousus H. (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. British Journal of Surgery, 88, 913–930.
- Shaw R.W., Bonnar J. and Geer I. (1995) Report of the RCOG Working Party on Prophylaxis Against Thromboembolism in Gynaecology and Obstetrics. Consensus report and review. London, RCOG.
- van Wijk F.H., Wolf H., Piek J.M.J. and Buller H.R. (2002) Administration of low molecular weight heparin within two hours before Caesarean section increases the risk of wound haematoma. British Journal of Obstetrics and Gynaecology, 109, 955–957.